14-91937102-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_006329.4(FBLN5):c.224T>C(p.Val75Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000116 in 1,614,074 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006329.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBLN5 | NM_006329.4 | c.224T>C | p.Val75Ala | missense_variant | Exon 4 of 11 | ENST00000342058.9 | NP_006320.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152064Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 30AN: 249046Hom.: 1 AF XY: 0.000104 AC XY: 14AN XY: 134820
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461892Hom.: 1 Cov.: 32 AF XY: 0.000120 AC XY: 87AN XY: 727248
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152182Hom.: 1 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74418
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
- -
- -
- -
This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 75 of the FBLN5 protein (p.Val75Ala). This variant is present in population databases (rs145108467, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FBLN5-related conditions. ClinVar contains an entry for this variant (Variation ID: 314881). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The p.Val75Ala variant in FBLN5 has not been previously reported in individuals with pulmonary disease, but has been identified in 7/66730 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145108467). Computational prediction tools and conservation analyses do not p rovide strong support for or against an impact to the protein. In summary, the c linical significance of the p.Val75Ala variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.224T>C (p.V75A) alteration is located in exon 4 (coding exon 4) of the FBLN5 gene. This alteration results from a T to C substitution at nucleotide position 224, causing the valine (V) at amino acid position 75 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Retinal dystrophy Uncertain:1
- -
Cutis Laxa, Dominant/Recessive Benign:1
- -
Macular degeneration Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at